{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T18:45:48Z","timestamp":1782845148547,"version":"3.54.5"},"reference-count":37,"publisher":"JMIR Publications Inc.","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JMIR Res Protoc"],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>ChAdOx-1s, CoronaVac, BBIBP-CorV, mRNA-1273, and BNT162b2 are the five common COVID-19 vaccines used in Jakarta. Randomized controlled trials have provided robust evidence of the safety and efficacy profile of these vaccines, but their real-world vaccine effectiveness against symptomatic COVID-19 and deaths in communities with social inequalities and health care constraints remains unclear.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>This study aims to evaluate the real-world effectiveness of these COVID-19 vaccines during the waves associated with the Delta and Omicron variants by analyzing existing electronic health care sources.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A population-based study with a test-negative case-control design will be used to evaluate COVID-19 vaccine effectiveness in Jakarta, focusing on the Delta and Omicron waves. It includes adults 18 years and older who underwent reverse transcription polymerase chain reaction testing for symptomatic COVID-19, classifying them as cases or controls based on their test results. The analysis will consider multiple COVID-19 vaccines introduced during these periods, with participants categorized by vaccination status. Several potential confounders will be assessed, including demographic factors and comorbidities. Data will be linked from various health datasets, and statistical analyses will be performed to determine vaccine effectiveness and potential waning immunity over time. After data linkage, patients\u2019 identities will be encrypted.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>The research, funded from 2022 to 2024, involved proposal preparation and ethical review in 2023 and enrollment from early 2024 to July 2024, resulting in about 4 million linked data points. Data analysis is ongoing, with initial results expected for publication in early 2025.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>This study will be the first to evaluate the effectiveness of different types of COVID-19 vaccines (inactivated, viral-vector, and mRNA) used in Jakarta during the pandemic, providing valuable scientific evidence to inform future vaccination strategies in the country.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>International Registered Report Identifier (IRRID)<\/jats:title>\n                    <jats:p>DERR1-10.2196\/56519<\/jats:p>\n                  <\/jats:sec>","DOI":"10.2196\/56519","type":"journal-article","created":{"date-parts":[[2025,2,4]],"date-time":"2025-02-04T08:26:35Z","timestamp":1738657595000},"page":"e56519","source":"Crossref","is-referenced-by-count":0,"title":["Real-World Effectiveness of COVID-19 Vaccines (ChAdOx-1s, CoronaVac, BBIBP-CorV, mRNA-1273, and BNT162b2) in Jakarta: Protocol for Test-Negative Design of Health Care Data"],"prefix":"10.2196","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8115-8293","authenticated-orcid":false,"given":"Erlina","family":"Burhan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-0327-4399","authenticated-orcid":false,"given":"Farchan","family":"Azzumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5935-8870","authenticated-orcid":false,"given":"Fira Alyssa Gabriella","family":"Sinuraya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8868-1004","authenticated-orcid":false,"given":"Muhammad Ilham Dhiya","family":"Rakasiwi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-9407-982X","authenticated-orcid":false,"given":"Ihya","family":"Akbar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-5737-7543","authenticated-orcid":false,"given":"Farhan","family":"Mubarak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-2285-9463","authenticated-orcid":false,"given":"Anggit Tresna","family":"Rengganis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4356-1222","authenticated-orcid":false,"given":"Rizky Abi","family":"Rachmadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-9748-3545","authenticated-orcid":false,"given":"Hera","family":"Afidjati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1010","published-online":{"date-parts":[[2025,4,10]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bj.2020.04.007"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.n1815"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.3389\/fpubh.2022.1048062"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1016\/j.therap.2021.05.004"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/j.hpopen.2022.100082"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1136\/bmjgh-2021-008329"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra1110897"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1007\/978-3-030-64569-4_7","author":"Rukmana, D","year":"2021","journal-title":"Urban Socio-Economic Segregation and Income Inequality: A Global Perspective"},{"key":"ref9","unstructured":"Data pemantauan COVID-19Jakarta Tanggap Covid-19202001212024-10-14https:\/\/corona.jakarta.go.id\/id\/data-pemantauan\/?utm_source=webCovid19&utm_medium=home"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1088\/1755-1315\/70\/1\/012059"},{"key":"ref11","unstructured":"Bahaya terselubung dibalik melesatnya gelombang ketiga Covid-19 di Indonesia [Article in Indonesian]Lapor Covid-192024-10-14https:\/\/laporcovid19.org\/post\/bahaya-terselubung-dibalik-melesatnya-gelombang-ketiga-covid-19-di-indonesia"},{"key":"ref12","unstructured":"SafitriKMovanitaANKLuhut: positivity rate Covid-19 varian delta turun hingga 50 persen [Article in Indonesian]Kompas202108022024-10-14https:\/\/money.kompas.com\/read\/2021\/08\/02\/151647626\/luhut-positivity-rate-covid-19-varian-delta-turun-hingga-50-persen"},{"key":"ref13","unstructured":"Positivity rate kasus omicron melandai [Article in Indonesian]Sehat Negeriku202203152025-02-24https:\/\/sehatnegeriku.kemkes.go.id\/baca\/rilis-media\/20220222\/0339374\/positivity-rate-kasus-omicron-melandai\/"},{"key":"ref14","unstructured":"MathieuERitchieHRod\u00e9s-GuiraoLAppelCGavrilovDGiattinoCHasellJCOVID-19 pandemicOur World in Data20202025-02-11https:\/\/ourworldindata.org\/coronavirus"},{"key":"ref15","unstructured":"Pemerintah terus pantau konsistensi tren penurunan kasus COVID-19 di sejumlah daerah [Article in Indonesian]Cabinet Secretariat of the Republic of Indonesia202202272024-10-14https:\/\/setkab.go.id\/pemerintah-terus-pantau-konsistensi-tren-penurunan-kasus-covid-19-di-sejumlah-daerah\/"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.3390\/v14040778"},{"key":"ref17","unstructured":"Laporan vaksinasi COVID-19Ministry of Health Republic of Indonesia2024-10-15https:\/\/layanandata.kemkes.go.id\/katalog-data\/covid-19\/visualisasi-data\/laporan-vaksinasi-covid-19"},{"key":"ref18","unstructured":"Badan POM terbitkan EUA, vaksin CoronaVac Sinovac siap disuntikkanIndonesian Food and Drug Authority202101112024-10-15https:\/\/www.pom.go.id\/berita\/badan-pom-terbitkan-eua-vaksin-coronavac-sinovac-siap-disuntikkan"},{"key":"ref19","unstructured":"Pastikan keamanan dan khasiat vaksin, BPOM lakukan pengawasan dan pendampinganMinistry of Communication and Digital Affairs Republic of Indonesia202108132024-10-15https:\/\/www.kominfo.go.id\/berita\/berita-pemerintahan\/detail\/pastikan-keamanan-dan-khasiat-vaksin-bpom-lakukan-pengawasan-dan-pendampingan"},{"key":"ref20","unstructured":"Penyuntikan vaksin booster untuk nakes dimulai di RSCM [Article in Indonesian]Ministry of Health Republic of Indonesia202107162024-10-15https:\/\/sehatnegeriku.kemkes.go.id\/baca\/rilis-media\/20210716\/0938147\/penyuntikan-vaksin-booster-untuk-nakes-dimulai-di-rscm\/"},{"key":"ref21","unstructured":"Kemenkes terbitkan surat edaran pelaksanaan vaksinasi booster di semua wilayah [Article in Indonesian]Ministry of Health Republic of Indonesia202201132024-10-15https:\/\/sehatnegeriku.kemkes.go.id\/baca\/rilis-media\/20220113\/4539153\/kemenkes-terbitkan-surat-edaran-pelaksanaan-vaksinasi-booster-di-semua-wilayah\/"},{"key":"ref22","unstructured":"Kemenkes: vaksinasi booster dapat dilakukan setelah tiga bulan vaksinasi dosis primer [Article in Indonesian]Cabinet Secretariat of the Republic of Indonesia202202272024-10-15https:\/\/setkab.go.id\/kemenkes-vaksinasi-booster-dapat-dilakukan-setelah-tiga-bulan-vaksinasi-dosis-primer\/"},{"key":"ref23","unstructured":"Tambah regimen baru vaksin booster, total ada 6 jenis vaksin COVID-19 yang dipakai di Indonesia [Article in Indonesian]Ministry of Health Republic of Indonesia202202282024-10-15https:\/\/sehatnegeriku.kemkes.go.id\/baca\/rilis-media\/20220228\/2439416\/tambah-regimen-baru-vaksin-booster-total-ada-6-jenis-vaksin-covid-19-yang-dipakai-di-indonesia\/"},{"key":"ref24","unstructured":"Evaluation of COVID-19 vaccine effectiveness: interim guidanceWorld Health Organization202103172024-10-15https:\/\/www.who.int\/publications\/i\/item\/WHO-2019-nCoV-vaccine_effectiveness-measurement-2021.1"},{"key":"ref25","unstructured":"Evaluation of COVID-19 vaccine effectiveness in a changing landscape of COVID-19 epidemiology and vaccination: second addendum to evaluation of COVID-19 vaccine effectiveness: interim guidanceWorld Health Organization202210032024-10-15https:\/\/www.who.int\/publications\/i\/item\/WHO-2019-nCoV-vaccine_effectiveness-VE_evaluations-2022.1"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1093\/oxfordjournals.aje.a116397"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2114114"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-021-01446-y"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1002\/sim.4780071208"},{"key":"ref30","doi-asserted-by":"crossref","DOI":"10.1002\/9781118548387","author":"Hosmer Jr, DW","year":"2013","journal-title":"Applied Logistic Regression"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.3389\/fpubh.2018.00057"},{"key":"ref32","author":"Rothman, KJ","year":"2018","journal-title":"Modern Epidemiology. 3rd ed"},{"key":"ref33","unstructured":"SeaboldSPerktoldJStatsmodels: econometric and statistical modeling with PythonProceedings of the 9th Python in Science Conference2010SciPy 2010June 28-July 3, 2010Austin, Texas"},{"key":"ref34","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0290652"},{"key":"ref35","unstructured":"Understanding and communicating about COVID-19 vaccine efficacy, effectiveness, and equityNational Academies of Sciences, Engineering, and Medicine20212024-10-15https:\/\/www.nap.edu\/catalog\/26154"},{"key":"ref36","unstructured":"Blueprint of digital health transformation strategy 2024Ministry of Health Republic of Indonesia20212024-10-15https:\/\/oss2.dto.kemkes.go.id\/artikel-web-dto\/ENG-Blueprint-for-Digital-Health-Transformation-Strategy-Indonesia%202024.pdf"},{"key":"ref37","doi-asserted-by":"publisher","DOI":"10.3390\/ijerph20054384"}],"container-title":["JMIR Research Protocols"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.researchprotocols.org\/2025\/1\/e56519","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T17:45:33Z","timestamp":1782841533000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.researchprotocols.org\/2025\/1\/e56519"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,10]]},"references-count":37,"URL":"https:\/\/doi.org\/10.2196\/56519","relation":{"has-preprint":[{"id-type":"doi","id":"10.2196\/preprints.56519","asserted-by":"object"}]},"ISSN":["1929-0748"],"issn-type":[{"value":"1929-0748","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,10]]}}}